Origin of SARS-CoV-2 theories, keys and unknowns of an emerged disease
e202009116
Keywords:
Zoonosis, SARS-CoV-2, Newly emerged disease, One-HealthAbstract
In the midst of the SARS-CoV-2 public-health pandemic emergency, it is important to understand its zoonotic origin and how an animal virus finally infects humans. Identifying the circumstances in which a virus jumps species boundaries to infect humans so productively is objective of this work and will help us to determine the epidemiology and pathogenisis of this agent.
Nowadays, it is known that bats serve as reservoir hosts for virus progenitor, but determine the possibility of a potential intermediate host of SARS-CoV-2 is still a challenge. Scientific investigations stablish the natural selection theory as the most probable (natural selection in an animal host before zoonotic transfer or acquired mutations in humans following crossing species barrier). It is necessary to find out how SARS-CoV-2 emerged, its rapidly spreads within a community and the optimal context in which this virus binds to human receptor.
One Health is a multisectoral, collaborative and transdisciplinary approach which allows a cooperative working between animal and human health that will help us to introduce some possible control measures that might reduce the spread of the virus; improving sanitary management, identifying new outbreaks and preventing future zoonotic and pandemic events.
Downloads
References
Organización de las Naciones Unidas para la alimentación y la agricultura (FAO). World Livestock – Changing disease landscapes. 2013; Rome. http://www.fao.org/3/i3440e/i3440e.pdf.
Fani M, Teimoori A, Ghafari S. Comparison of COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections. Future Virol. 2020; May : 10.2217/fvl-2020-0050.
Institute of Medicine (US) Committee on Emerging Microbial Threats to Health, Lederberg J, Shope RE, Oaks SC Jr., eds. Emerging Infections: Microbial Threats to Health in the United States. Washington (DC): National Academies Press (US); 1992.
McCarthy AJ, Shaw MA, Goodman SJ. Pathogen evolution and disease emergence in carnivores. Proc Biol Sci. 2007;274(1629):3165-3174.
Organización Mundial de Sanidad animal (OIE). Una sola salud. https://www.oie.int/es/para-los-periodistas/una-sola-salud/.
Bloom DE, Cardarette D. Infectious Disease Threats in the Twenty-First Century: Strengthening the Global Response Frontiers in immunology. Front Immunol. 2019; 10: 549.
Häsler B, Cornelsen L, Bennani H, Rushton J. A review of the metrics for One Health benefits. Rev sci tech Off int Epiz. 2014,33(2),453-464.
Kim YI, Kim SG, Kim SM, Kim EH, Park SJ, Yu KM et al. Infection and Rapid Transmission of SARS-CoV-2 in Ferrets. Cell Host Microbe. 2020; 13;27(5):704-709.
Saif LJ. Animal coronaviruses: Lessons for SARS. 2004 En: Institute of Medicine (US) Forum on Microbial Threats; Knobler S, Mahmoud A, Lemon S, et al., editors. Learning from SARS: Preparing for the Next Disease Outbreak: Workshop Summary. Washington (DC): National Academies Press (US).
Decaro N, Martella V, Saif LJ, Buonavoglia C. COVID-19 from veterinary medicine and one health perspectives: What animal coronaviruses have taught us. Res Vet Sci. 2020;131:21-23.
Sun J, He WT, Wang L, Lai A, Ji X, Zhai X et al. COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives. Trends Mol Med. 2020;26(5):483-495.
Holmes K. Coronavirus (Coronaviridae). En: Enciclopedia de Virología (1999): 291-298.
Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol. 2009;7(6):439-450.
Malik YS, Sircar S, Bhat S, Sharun K, Dhama K, Dadar M et al. Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments. Vet Q. 2020; 40(1): 68–76.
Di Mauro G, Scavone C, Concetta R, Rossi F, Capuano A. SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment. Int Immunopharmacol. 2020;84:106519.
Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020; 26:450–452.
Leroy EM, Ar-Gouilh M, Brugère-Picoux J. The risk of SARS-CoV-2 transmission to pets and other wild and domestic animals strongly mandates a one-health strategy to control the COVID-19 pandemic [published online ahead of print, 2020 Apr 13]. One Health. 2020;100133. doi: 10.1016/j.onehlt.2020.100133.
Briones C, Peretó, J. El origen del coronavirus SARS-CoV-2, a la luz de la evolución, (2020) [citado 21 abril 2020], https://theconversation.com/el-origen-del-coronavirus-sars-cov-2-a-la-luz-de-la-evolucion-136897.
Reina J. El SARS-CoV-2, una nueva zoonosis pandémica que amenaza al mundo. Vacunas. 2020 [published online ahead of print, 2020 Apr 5]. J vacun. 2020 DOI: 10.1016/j.vacun.2020.03.001.
Boni MF, Lemey P, Jiang X, Lam TT-Y, Perry B, Castoe A et al. Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic [published online ahead of print, 2020 March 31] bioRxiv doi: https://doi.org/10.1101/2020.03.30.015008.
Genbank. Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome. NCBI Reference Sequence: NC_045512.2.
Chan JFW, Kok, KH, Zhu Z, Chu H, To KKW, Yuan S et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg microbes infect, 2020; 9(1): 221-236.
Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11.
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579:265–269.
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579, 270–273.
Cyranosky D. Did pangolins spread the China coronavirus to people? Nature. 2020 [citado 7 febrero 2020] https://www.nature.com/articles7d41586-020-000364-2.
Shi Z, Hu Z. A review of studies on animal reservoirs of the SARS coronavirus. Virus Res. 2008;133(1):74-87.
Pérez- Sancho M, Briones Dieste V, Rodríguez Ferri EF, Álvarez Sánchez J, Domínguez Rodríguez L. Implicación animal en la aparición de SARS-CoV-2. Revista visavet divulgación. 4 abril disponible en: https://www.visavet.es/es/articulos/COVID-19_SARS-CoV-2_animales_domesticos.php?fbclid=IwAR2XEe_f7unSPthO1c4Kupwgy1fFB01wToSyeU-cq6GfoK3oHXoHWyNzTLc. 5 de mayo de 2020.
Cyranosky D. Mystery deepens over animal source of coronavirus. Nature. 2020 [citado 26 febrero 2020]
http://www.nature.com/articles/d41586-020-00548-w.
Temmam S, Barbarino A, Maso D, Behillil S, Enouf V, Huon C et al. Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus. [published online ahead of print, 2020 Apr 9] bioRxiv. 2020; doi: https://doi.org/10.1101/2020.04.07.029090.
Mallapaty S. Animal source of the coronavirus. [published online ahead of print, 2020 May 18]. Nature. 2020 doi: 10.1038/d41586-020-01449-8.
Xu Y. Unveiling the origin and transmission of 2019-nCoV. Trends Microbiol. 2020; 28(4): 239–240.
Liu Z, Xiao X, Wei X, Li J, Yang J, Tan H et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. [published online ahead of print, 2020 Feb 26]. J Med Virol. 2020; doi: 10.1002/jmv.25726.
Zhang T, Wu Q, Zhang Z. Pangolin homology associated with 2019-nCoV. [published online ahead of print, 2020 Feb 20] bioRxiv. 2020; doi: https://doi.org/10.1101/2020.02.19.950253.
Latham J, Wilson A. A proposed origin for SARS-CoV-2 and the COVID-19 pandemic. Biotechnology commentaries health. [citado 15 julio 2020]. https://www.independentsciencenews.org/commentaries/a-proposed-origin-for-sars-cov-2-and-the-covid-19-pandemic/.
Nao N, Yamagishi J, Miyamoto H, Igarashi M, Manzoor R, Ohnuma A et al. Genetic predisposition to acquire a polybasic cleavage site for highly pathogenic avian influenza virus hemagglutinin. mBio. 2017; 8(1):e02298-16.
https://doi.org/10.1128/mBio.02298-16.
Menachery VD, Dinnon III KH, Yount Jr. BL, McAnarney ET, Gralinski LE, Hale A et al. Trypsin treatment unlocks barrier for zoonotic bat coronavirus infection. J Virol. 2020; 94: e01774-19.
https://doi.org/10.1128/JVI.01774-19.
Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS Coronavirus. J. Virol. 2020; 94(7):e00127-20.
https://doi.org/10.1128/JVI.00127-20.
Shi J, Wen Z, Zhong G, Yang H, Wang C, Huang B et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2. [published online ahead of print, 2020 Apr 8]. Science. 2020; eabb7015.
doi: 10.1126/science.abb7015.
Mallapaty S. Coronavirus can infect cats-dogs, not so much. [published online ahead of print, 2020 Feb 1]. Nature. doi: 10.1038/d41586-020-00984-8.
Piplani S, Singh PK, Winkler DA,Petrovsky N. In silico comparison of spike protein-ACE2 binding affinities across species; significance for the possible origin of the SARS-CoV-2 virus. 2020 arXiv:2005.06199. [published online ahead of print, 2020 May 13].
Almazán F, Sola I, Zuñiga S, Marquez-Jurado S, Morales L, Becares M et al. Reprint of: Coronavirus reverse genetic systems: Infectious clones and replicons. Virus Res. 2014; 194: 67–75.
Figueras Huerta A, Novoa B, Fernando González Candelas F. El virus de la COVID-19 ni se creó ni se escapó de un laboratorio (2020) [citado 20 abril 2020],
https://theconversation.com/el-virus-de-la-covid-19-ni-se-creo-ni-se-escapo-de-un-laboratorio-136773.
Zhang Y-Z, Holmes EC. A Genomic perspective on the origin and emergence of SARS-CoV-2. Cell. 2020. 16;181(2):223-227.
Zhou H, Chen X, Hu T, Li J, Song H, Liu Y et al. A novel bat coronavirus reveals natural insertions at the S1/S2 cleavage site of the Spike protein and a possible recombinant origin of HCoV-19. bioRxiv 2020. 10.1101/2020.03.02.974139.
Dudas G, Rambaut A. MERS-CoV recombination: implications about the reservoir and potential for adaptation. Virus evol. 2016; 2(1).
Brussow H. The Novel Coronavirus - A Snapshot of current knowledge. Microb Biotechnol. 2020; 13(3):607-612.
Stegeman A, Bouma A, Elbers ARW, De Jong MCM, Nodelijk G, De Klerk F et al. Avian influenza A virus ( H7N7 ). Epidemic in the Netherlands in 2003: course of the epidemic and effectiveness of control measures. J Infect Dis. 2004. 190:2088–2095.
Rambaut A. Phylogenetic analysis of nCoV-2019 genomes, 6 de marzo 2020 disponible en: http://virological.org/t/phylodynamic-analysis-176-genomes-6-mar-2020/356 29 de abril de 2020.
Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019; 17:181-192.
Su S. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016;24:490–502.
Dudas G, Carvalho LM, Rambaut A, Bedford T. Correction: MERS-CoV spillover at the camel-human interface. eLife. 2018, 7:e31257. https://elifesciences.org/articles/37324.
Sheahan T, Rockx B, Donaldson E, Sims A, Pickles R, Corti D et al. Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium. J. Virol. 2008;82(5):2274-2285.
Bagdonaite I, Wandall HH. Global aspects of viral glycosylation Glycobiology. 2018;28(7):443-467.
Zhan S H, Deverman B E, Chan YA. (2020). SARS-CoV-2 is well adapted for humans. What does this mean for re-emergence?. bioRxiv. (2020). [published online ahead of print, 2020 May 2]. doi: https://doi.org/10.1101/2020.05.01.073262
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2020 Rosa M. Estévez Reboredo
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
